Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.1K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.6K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.6K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.6K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

544
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
544
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-Site Activation of High-Entropy Alloy Electrocatalysts via Ruthenium-Induced Electron Transfer for Alkaline Hydrogen Evolution.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Deep Learning Analysis of Prenatal Ultrasound for Identification of Ventriculomegaly.

Ultrasound in medicine & biology·2026
Same author

Long-term effectiveness of titanium dioxide-silver composite coating in reducing healthcare-associated infections in chronic respiratory care wards: a controlled trial.

BMC infectious diseases·2026
Same author

Augmenting Performance Status: A Preliminary Study of Objective Kinematic Assessment Using Motion Capture.

Oncology and therapy·2026
Same author

Analytical Models to Optimize Tacrolimus Dosing in Solid Organ Transplantation: A Systematic Review.

Pharmaceutics·2026
Same author

Sound and Vibration Exposure During Fixed-Wing Aircraft Neonatal Patient Transport.

Air medical journal·2026

Related Experiment Video

Updated: Sep 2, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K

Reciprocal perspective as a super learner improves drug-target interaction prediction (MUSDTI).

Kevin Dick1,2, Daniel G Kyrollos3,4, Eric D Cosoreanu3

  • 1Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada. kevin.dick@carleton.ca.

Scientific Reports
|August 2, 2022
PubMed
Summary

This study introduces a novel meta-model for predicting drug-target interactions (DTI) by combining student-developed deep learning models. The new approach, MUSDTI, achieves state-of-the-art performance, improving drug discovery and repurposing efforts.

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

Related Experiment Videos

Last Updated: Sep 2, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

Area of Science:

  • Computational chemistry
  • Machine learning
  • Pharmacology

Background:

  • Accurate drug-target interaction (DTI) prediction is crucial for drug discovery and repurposing, especially for emergent diseases.
  • Traditional binary classification for DTI prediction is less informative than predicting physiochemical binding affinity.
  • Deep learning models show promise for DTI prediction with increasing experimental data availability.

Purpose of the Study:

  • To develop a novel meta-model for DTI prediction by ensembling student-generated deep learning models.
  • To evaluate the effectiveness of the Reciprocal Perspective (RP) multi-view learning framework in DTI prediction.
  • To establish a new benchmark for DTI prediction, particularly for emergent challenges.

Main Methods:

  • Formulated a DTI prediction competition for an undergraduate machine learning course.
  • Students developed 28 component deep learning DTI models.
  • Combined component models using the Reciprocal Perspective (RP) multi-view learning framework to create the MUSDTI meta-model.
  • Employed a double-cold experimental design for evaluating model performance.

Main Results:

  • The MUSDTI meta-model, utilizing RP, achieved state-of-the-art (SOTA) performance in DTI prediction.
  • RP significantly improved upon existing SOTA DTI prediction models.
  • The double-cold experimental design proved suitable for emergent DTI prediction scenarios.
  • RP demonstrated effectiveness as an ensembling method and for low-computation transfer learning.

Conclusions:

  • The MUSDTI meta-model represents a significant advancement in DTI prediction.
  • The Reciprocal Perspective (RP) framework offers a powerful approach for ensembling and improving DTI prediction models.
  • This work provides valuable insights for sequence-based, pairwise prediction tasks in computational biology and drug discovery.